Ubs Group Ag Cardlytics, Inc. Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Cardlytics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 171,516 shares of CDLX stock, worth $222,970. This represents 0.0% of its overall portfolio holdings.
Number of Shares
171,516
Previous 188,769
9.14%
Holding current value
$222,970
Previous $700,000
55.43%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding CDLX
# of Institutions
122Shares Held
29.4MCall Options Held
282KPut Options Held
493K-
Cliff Sosin Cas Investment Partners, LLC | New York, Ny5.61MShares$7.3 Million0.66% of portfolio
-
Black Rock Inc. New York, NY3.15MShares$4.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$3.47 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY1.55MShares$2.02 Million0.23% of portfolio
-
Kps Global Asset Management Uk LTD London, X01.22MShares$1.58 Million0.45% of portfolio
About Cardlytics, Inc.
- Ticker CDLX
- Exchange NASDAQ
- Sector Communication Services
- Industry Advertising Agencies
- Shares Outstandng 32,893,800
- Market Cap $42.8M
- Description
- Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...